A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted insider buying at some biotech companies.
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the country ages;…
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Apple, AT&T, Cenovus Energy, Dollar General, Dynatrace, FedEx, Molson Coors Beverage, NiSource, Uber Technologies and Vale.
Wednesday's top analyst upgrades and downgrades included Albemarle, Boeing, Ingersoll-Rand, Novo Nordisk, Nutrien, Palantir Technologies, PayPal, Shoals Technologies, Shopify, Skyworks Solutions, Walmart and XPO.
Tuesday’s additional top analyst upgrades and downgrades were on BHP, Booz Allen Hamilton, Devon Energy, Mirati Therapeutics, Novo Nordisk, NRG Energy and more.
Tuesday’s additional top analyst upgrades and downgrades included Dow, Estee Lauder, Magellan Midstream Partners, Nektar Therapeutics, Novo Nordisk, Rocket Companies, Sherwin-Williams, Steel Dynamics and Zoom Video Communications.
Thursday's top analyst upgrades and downgrades included Adobe, American Airlines, Coupa Software, Delta Air Lines, Host Hotels & Resorts, Nio, Novo Nordisk, Ralph Lauren, Roblox, SentinelOne and Walt Disney.
The top analyst upgrades, downgrades and initiations for Friday included Abercrombie, Ambarella, Best Buy, Dollar General, Novo Nordisk, Ulta Beauty and Whiting Petroleum.
The top analyst upgrades, downgrades and initiations seen on Monday included Apple, Baker Hughes, Conagra Brands, Facebook, General Electric, Halliburton, Petrobras, Schlumberger, Vodafone and Walmart.
The include BioCryst Pharmaceuticals, Exxon Mobil, Fiat Chrysler Automobiles, Hewlett Packard Enterprise, IAMGOLD, Mallinckrodt and Rockwell Collins.
The top analyst upgrades, downgrades and initiations seen from Friday include AECOM, Apache, Panera, Sunoco and Wal-Mart.
2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.
November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2.5 to…
November 18, 2016: Here are four stocks trading with relatively heavy volume among 39 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by nearly 3 to…
November 18, 2016: Here are four stocks trading with relatively heavy volume among 46 equities making new 52-week lows in Friday’s session. On the NYSE, advancers and decliners traded about equally and…
